Show simple item record

dc.creatorSimopoulou M., Sfakianoudis K., Maziotis E., Tsioulou P., Giannelou P., Grigoriadis S., Pantou A., Anifandis G., Christopoulos P., Pantos K., Koutsilieris M.en
dc.date.accessioned2023-01-31T09:56:20Z
dc.date.available2023-01-31T09:56:20Z
dc.date.issued2019
dc.identifier10.21873/invivo.11664
dc.identifier.issn0258851X
dc.identifier.urihttp://hdl.handle.net/11615/78995
dc.description.abstractBackground/Aim: Studies on the impact of intrauterine human Chorionic Gonadotropin (hCG) administration in order to improve the In Vitro Fertilization (IVF) outcome have yielded conflicting results. The aim of the present systematic review and meta-analysis is to investigate whether timing of intrauterine hCG administration prior to embryo transfer affects its efficiency. Materials and Methods: A systematic search of the literature on Pubmed/Medline, Embase and Cochrane databases was performed. Only Randomized Control Trials were included in this meta-analysis. Results: Live birth rates were not improved following hCG administration (RR=1.13, 95%CI=0.88-1.46, p=0.34) in the pooled results. Combined live birth and ongoing pregnancy rates were borderline statistically significant following hCG administration (RR=1.27, 95%CI=1.00-1.62, p=0.05). Following subgroup analysis regarding live birth and ongoing pregnancy rates, only the 5-12 minutes prior to the embryo transfer group reported a statistically significant improvement. Conclusion: Intrauterine infusion of hCG within an IVF-Intracytoplasmic Sperm Injection (ICSI) cycle improves outcome only when administered 5-12 min prior to embryo transfer. © 2019 International Institute of Anticancer Research. All rights reserved.en
dc.language.isoenen
dc.sourceIn Vivoen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074203528&doi=10.21873%2finvivo.11664&partnerID=40&md5=be2ed7bf8a8fbfa5dbcb67b13cd46d53
dc.subjectchorionic gonadotropinen
dc.subjectchorionic gonadotropinen
dc.subjectclinical outcomeen
dc.subjectembryo transferen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectin vitro fertilizationen
dc.subjectinfusionen
dc.subjectlive birthen
dc.subjectmeta analysisen
dc.subjectpregnancy outcomeen
dc.subjectpregnancy rateen
dc.subjectReviewen
dc.subjectspontaneous abortionen
dc.subjectsystematic reviewen
dc.subjecttime to treatmenten
dc.subjectanimalen
dc.subjectfemale infertilityen
dc.subjectin vitro fertilizationen
dc.subjectpregnancyen
dc.subjectproceduresen
dc.subjectAnimalsen
dc.subjectChorionic Gonadotropinen
dc.subjectEmbryo Transferen
dc.subjectFemaleen
dc.subjectFertilization in Vitroen
dc.subjectHumansen
dc.subjectInfertility, Femaleen
dc.subjectLive Birthen
dc.subjectPregnancyen
dc.subjectPregnancy Rateen
dc.subjectInternational Institute of Anticancer Researchen
dc.titleInvestigating the optimal time for intrauterine human chorionic gonadotropin infusion in order to improve IVF outcome: A systematic review and meta-analysisen
dc.typeotheren


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record